International Guideline Harmonization Group
  • Home
  • About IGHG
    • Members
      • Core group
      • Guideline panels
        • Breast cancer
        • Cardiomyopathy
        • Premature ovarian insufficiency
        • Male gonadotoxicity
        • Thyroid cancer
        • Ototoxicty
        • Obstetric care
        • Central nervous system neoplasms
        • Fatigue, mental health and psychosocial problems
        • Fertility preservation
        • Hypothalamic-pituitary dysfunction
        • Coronary artery disease
        • Metabolic syndrome
        • Pulmonary dysfunction
        • Bone toxicity
        • Hepatic toxicity
        • Nephrotoxicity
        • Neurocognitive problems
        • Colorectal cancer
        • Thyroid dysfunction
    • Collaborators
    • Funding sources
    • Methods
      • Process
      • Grading system
      • Topic selection
      • Publication
      • Handbook
  • Guidelines
    • Topics
      • Breast cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Cardiomyopathy
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Premature ovarian insufficiency
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Male gonadotoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Thyroid cancer
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Ototoxicity
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Obstetric care
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Central nervous system neoplasms
        • Guideline panel
      • Fatigue
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publication
        • Guideline panel
      • Psychosocial problems
        • Guideline panel
      • Mental health problems
        • Guideline panel
      • Fertility preservation
        • Recommendations
        • Conclusions of evidence
        • Evidence tables
        • Publications
        • Guideline panel
      • Hypothalamic-pituitary dysfunction
        • Guideline panel
      • Coronary artery disease
        • Guideline panel
      • Metabolic syndrome
        • Guideline panel
      • Pulmonary dysfunction
        • Guideline panel
      • Bone toxicity
        • Guideline panel
      • Hepatic toxicity
        • Guideline panel
      • Nephrotoxicity
        • Guideline panel
      • Colorectal cancer
        • Guideline panel
      • Neurocognitive problems
        • Guideline panel
      • Thyroid dysfunction
        • Guideline panel
  • Patient education
  • News
  • Meetings
  • Contact

News

Home News

News archive

  • October 2020
  • September 2020
  • April 2020
  • February 2019
  • January 2017
  • August 2016
  • July 2016
  • April 2015
  • September 2014
  • October 2013
  • July 13, 2016

    Update handbook guideline development

    The update of the Handbook for Guideline Development is now available.

    Read more
  • April 13, 2015

    Cardiomyopathy surveillance recommendations published

    The cardiomyopathy surveillance recommendations have been published in The Lancet Oncology 2015;16:e123-136.

    Read more
  • September 11, 2014

    Kick off expert panel central nervous system neoplasms

    We will soon initiate the harmonization of the central nervous system neoplasm surveillance recommendations. Helena van der Pal from the Emma Children’s Hospital / Academic Medical Center, Amsterdam, the Netherlands and Daniel Bowers from

    Read more
12345
  • Contact
  • Disclaimer

© International Guideline Harmonization Group